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Available online 22 July 2016SinceMarch 2013, it is no longer possible tomarket in the European Union (EU) cosmetics containing new ingre-
dients tested on animals. Although several in silico alternatives are available and achievements have been made
in the development and regulatory adoption of skin sensitisation non-animal tests, there is not yet a generally
accepted approach for skin sensitisation assessment that would fully substitute the need for animal testing.
The aim of this work was to build a deﬁned approach (i.e. a predictive model based on readouts from various in-
formation sources that uses a ﬁxed procedure for generating a prediction) for skin sensitisation hazard prediction
(sensitiser/non-sensitiser) using Local Lymph Node Assay (LLNA) results as reference classiﬁcations. To derive
the model, we built a dataset with high quality data from in chemico (DPRA) and in vitro (KeratinoSens™ and
h-CLAT) methods, and it was complemented with predictions from several software packages.
The modelling exercise showed that skin sensitisation hazard was better predicted by classiﬁcation trees based
on in silico predictions.
The deﬁned approach consists of a consensus of two classiﬁcation trees that are based on descriptors that account
for protein reactivity and structural features. Themodel showed an accuracy of 0.93, sensitivity of 0.98, and spec-
iﬁcity of 0.85 for 269 chemicals. In addition, the deﬁned approach provides ameasure of conﬁdence associated to
the prediction.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Decision tree1. Introduction
The assessment of skin sensitisation potential represents a key re-
quirement within several pieces of chemicals' regulations in the EU. For
example, the REACH regulation (EC, 2006) foresees that chemicals pro-
duced or marketed in quantities of one tonne or more per annum be
assessed for their potential to cause allergic contact dermatitis in humans,
and within the Cosmetics Regulation (EC, 2009) skin sensitisation is one
of the toxicological endpoints that require particular focus. The REACH
regulation demands that testing on vertebrate animals should be consid-
ered only as last resort. The Cosmetics Regulation banned the animal test-
ing of cosmetic ingredients in 2009 and the marketing of cosmetics
containing new ingredients tested on animals in 2013 (EC, 2009).
The main chemical and biological mechanisms underpinning skin
sensitisation are established (Karlberg et al., 2008; Martin, 2015;
Martin et al., 2011) and have been described in the form of an adverse
outcome pathway (AOP) (OECD, 2012a,b). Within this AOP, four key
events (KE) are considered necessary for the acquisition of skin sensiti-
sation: the covalent binding to skin proteins (KE-1) – also considered to
be themolecular initiating event (MIE) –, the activation of keratinocytesectorate General Joint Research
ce Materials; Chemicals Safety
Asturiol).
. This is an open access article under(KE-2), the maturation of dendritic cells (KE-3), and the activation and
proliferation of memory T-cells.
Progress has been made over the past ten years in the development
of non-testing and testing methods addressing the key events of the
skin sensitisation AOP. Three animal-free methods that account for
KEs 1, 2, and 3 have been formally assessed by the European Union Ref-
erence Laboratory for Alternatives to Animal Testing (EURL ECVAM).
These methods are: the direct peptide reactivity assay (DPRA) (EURL
ECVAM, 2013; Gerberick et al., 2004), KeratinoSens™ (Emter et al.,
2010; EURL ECVAM, 2014; Natsch and Emter, 2008), and the human
cell-line activation test (h-CLAT) (Ashikaga et al., 2006; EURL ECVAM,
2015; Sakaguchi et al., 2006).
The DPRA, KeratinoSens™, and h-CLAT have been adopted by the
Organisation for Economic Cooperation and Development (OECD) as
Test Guidelines 442C (OECD, 2015a) and 442D (OECD, 2015b) and
442E (not yet published), respectively. Despite these methods predict
LLNA responses with an accuracy of about 80% they are not proposed
to be used as standalone alternatives. One of the reasons put forward
for this is that they model speciﬁc KEs of the AOP and not the ﬁnal ad-
verse effect.
Progress has been made in the integration of results from in silico, in
chemico and in vitro methods in deﬁned approaches (OECD, 2016a,
2016b) to improve skin sensitisation hazard/potency prediction with
respect to the individual methods. The ﬁrst approach of this kind was
developed by Natsch et al. (Natsch et al., 2009). The authors made athe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Jowsey et al. (Jowsey et al., 2006), which was intended for predicting
skin sensitisation potency. Themodel did not predict LLNApotency suc-
cessfully, but a good performancewas achieved in predicting skin sensi-
tisation hazard for 116 chemicals (sensitivity= 0.86, speciﬁcity= 0.94,
and accuracy = 0.88). Since then, a number of other approaches inte-
gratingnon-animal datawhich use the AOPas a framework and are pro-
posed for skin sensitisation hazard and/or potency assessments have
been published. These range from simple weight-of-evidence (WoE)
approaches (e.g. Bauch et al., 2012; Guyard-Nicodème et al., 2015;
Macmillan et al., 2016; Urbisch et al., 2015), tiered approaches involving
interim decision steps at the end of each tier (e.g. Takenouchi et al.,
2015; van der Veen et al., 2014), and multiple regression models
(Natsch et al., 2015) to more complex mathematical models (MacKay
et al., 2013), artiﬁcial neural networks (e.g. Hirota et al., 2013, 2015;
Tsujita-Inoue et al., 2014), and support vector machine-based ap-
proaches (Strickland et al., 2016). Another model integrating data
from various sources and developed for LLNA potency prediction is
the one based on a Bayesian Network (Jaworska, 2011; Jaworska et al.,
2013, 2015). Bayesian networks are probabilistic models that can
work with data gaps and can guide additional testing by quantifying
the additional test information value before performing the testing.
Some authors have analysed in detail the performance of various in
silico methods and expert systems when predicting skin sensitisation
potential (Teubner et al., 2013; van der Veen et al., 2014). They showed
that in general this kind of skin sensitisation methods had sensitivities
above 0.70 and speciﬁcities below 0.65, even when some of them
were combined. They concluded that the methods evaluated were not
sufﬁciently accurate to be broadly used for skin sensitisation prediction.
Alves et al. (Alves et al., 2015) recently showed that random forest
models built from in silico descriptors obtained from the 2D structure
of chemicals can have higher accuracy and larger applicability domains
than the in silicomethods reviewed by Teubner et al. and van der Veen
et al. Alves et al. developed a series of consensus random forest models
that predict skin sensitisation hazard (sensitiser vs.non sensitiser) using
LLNA results as reference data. Theirmodels used descriptors calculated
with Dragon (Talete Srl, 2010) and SiRMS (Muratov et al., 2010) and
were applied to a total of 406 chemicals, the largest skin sensitisation
dataset published to date. The authors ﬁnally used a model based on a
consensus of random forests that showed anaccuracy of 0.82, sensitivity
of 0.79, and speciﬁcity of 0.85 for the training set. These predictive per-
formance values were obtained for 82% of the chemicals of the training
set (chemical space coverage = 82%) as the predictions of the remain-
ing 18% of chemicals were discarded because the two forests had con-
tradictory outputs and the overall prediction was considered
equivocal. The corresponding statistics for the validation set are not re-
ported here as they are not representative because the validation set
was highly unbalanced, i.e. contained 152 sensitisers and only 5 non-
sensitisers. It is worth mentioning that the coverages of the validation
sets of the different models developed by Alves et al. were signiﬁcantly
lower than those of the training sets, being of 50% the highest amount of
chemicals of the validation tests that could be predicted.
The aim of our work was to build a model for predicting skin sensi-
tisation hazard (sensitiser/non-sensitiser) that was simple, accurate,
highly sensitive, and if possible integrating data from different sources,
i.e. a deﬁned approach. In order to develop the best model possible we
have built a high quality database of 269 chemicals with LLNA data
and skin sensitisation results obtained from DPRA, KeratinoSens™,
and h-CLAT. The dataset has been quality checked by EURL ECVAM in
collaboration with the test developers, and has been completed with a
number of descriptors predictedwith several free and licensed software
packages yielding about 4500 descriptors for each of the 269 chemicals.
This database has been used to build different classiﬁcation trees to pre-
dict skin sensitisation hazard using LLNA results as reference. The two
trees with the highest speciﬁcities and accuracies against LLNA classiﬁ-
cations were used in a conservative consensus approach as ﬁnalprediction model. In addition, a qualitative conﬁdence measure on the
prediction was added to the model by taking into account the leaves
that were used in each individual tree to obtain the ﬁnal consensus
prediction.
2. Materials and methods
2.1. Dataset compilation
A dataset of 269 organic chemicals (170 sensitisers and 99 non
sensitisers) identiﬁed by their chemical name and SMILES codes with
in chemico, in vitro, and in vivo skin sensitisation data (LLNA and
human) was built to develop a model to predict skin sensitisation
hazard.
The initial collected dataset contained a total of 315 substances
with human and/or LLNA data. Of these, 22 substances with
only human data available were not considered. 16 inorganic
chemicals and two mixtures (Pepperwood and Kathon CG) were
discarded since they could not be calculated with most in silico
software packages. Ammonium peroxodisulphate was also discarded
because it was considered an inorganic chemical by TIMES (Dimitrov
et al., 2005b), and 1,6-diisocyanatohexane, methylisoeugenol, 4-
methylcatechol, diphenylmethane-4,4′-diisocyanate, and 4-nitrobenzyl
chloride were discarded because they were considered as sensitisers or
respiratory sensitisers in the sources but had no associated LLNA EC3
values, which was interpreted as an indication of lower quality data.
The remaining 269 chemicals were used for modelling.
Thedataset canbe found in theSupporting Information (SI_Dataset.xls)
and contains: name, SMILES, human skin sensitisation classiﬁcation (1
to 6 categories), NOEL values (μg/cm2) (Basketter et al., 2014), human
GHS derived classiﬁcations (1A, 1B, NS), the LLNA EC3 values obtained
from the different sources with a corresponding ﬁnal call made by the
authors for those cases in which multiple LLNA studies were available
for the same chemical, and the in chemico and in vitro readouts that
are explained in the next section. Binary descriptors indicating positive
or negative predictions for each of the methods and the LLNA skin sen-
sitisation hazard are also included in the dataset. In addition, the values
of DRAGON and TIMES-SS descriptors used in the consensus model, a
column indicating the use given to each chemical for each tree (i.e.
training set, test set, or external test set), and the ﬁnal consensus
model predictions with the corresponding qualitative conﬁdence mea-
sures are reported.
2.2. In chemico and in vitro data
The non-animal data included in the dataset were those generated
with the three validated and OECD adopted methods, i.e. DPRA,
KeratinoSens™, and h-CLAT, and were obtained from the validation
study reports (EURL-ECVAM, 2012, 2015; EURL-ECVAM, 2014) and
the scientiﬁc literature (Bauch et al., 2012; Emter et al., 2010;
Gerberick et al., 2004, 2007; Natsch and Emter, 2008; Natsch et al.,
2013; Nukada et al., 2013; Takenouchi et al., 2013).
The DPRA (OECD, 2015a) is an in chemicomethod which addresses
peptide reactivity, considered to be the Molecular Initiating Event
(MIE) or Key Event (KE)-1 in the skin sensitisation AOP (OECD,
2012a), bymeasuring the depletion of synthetic heptapeptides contain-
ing either cysteine or lysine following 24 hour incubation with a single
concentration of the test substance. Depletion of the peptide in the reac-
tion mixture is measured by HPLC using UV detection. Average peptide
depletion data for cysteine and lysine are interpreted using a classiﬁca-
tion model in which chemicals classiﬁed as having minimal reactivity
are considered to lack skin sensitisation potential whereas chemicals
classiﬁed as having low, moderate, or high reactivity are considered to
be skin sensitisers. DPRA data included in the datasetwere: a) the % cys-
teine and b) the % lysine depletion values, c) average of cysteine and ly-
sine depletion values, d) the DPRA positive or negative prediction, and
Table 1
List of chemicals with data from different sources that were merged into single entries.
CAS from sources Names from sources Data merged into
1405-10-3
1404-04-2
Neomycin
Neomycin sulphate
Neomycin
59-01-8
64013-70-3
8063-07-8
Kanamycin (Streptomyces)
Kanamycin monosulphate
Kanamycin disulphate
Kanamycin
19317-11-4
502-67-0
Farnesal (mixture)
Farnesal (speciﬁc isomer)
Farnesal
69-57-8
61-33-6
61-33-6
Penicillin G sodium salt
Penicillin G (free acid)
Penicillin Potassium salt
Penicillin G
104-55-2
14371-10-9
Cinnamic aldehyde
Cinnamaldehyde-hydro
Cinnamic aldehyde
127-65-1
149358-73-6
Chloramine T
Chloramine T
Chloramine T
10191-41-0
59-02-9
(±)-α-Tocopherol
Tocopherol
Tocopherol
18031-40-8
2111-75-3
Perillaldehyde
Perillaldehyde
Perillaldehyde
5989-27-5
138-86-3
D-Limonene (pure isomer)
Limonene (racemic mixture)
D-Limonene
99-49-0
6485-40-1
S-Carvone
R-Carvone
Carvone
69-09-0
50-53-3
Chlorpromazine hydrochloride
Chlorpromazine
Chlorpromazine
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the substance.
KeratinoSens™ (OECD, 2015b) is a luciferase reporter gene assay in
which quantiﬁcation of the luciferase gene is used as an indicator of the
activity of the Nrf2 transcription factor in keratinocytes following
48 hour exposure to twelve serial concentrations of the test substance.
By measuring activation of a relevant pathway in keratinocytes, the
KeratinoSens™ is addressing KE-2 of the skin sensitisation AOP.
KeratinoSens™ readouts included in the dataset were: a) the IC50
value, i.e. the concentration of test chemical yielding 50% reduction in
cell viability; b) the EC 1.5, EC 2.0 and the EC 3.0 values, i.e. the extrap-
olated concentration of test chemical inducing the luciferase activity
above the 1.5-fold, 2-fold, and 3-fold thresholds, respectively; c) the
Imax value, i.e. the maximal fold induction of the luciferase activity
over the negative control (solvent); and d) the KeratinoSens™ positive
or negative prediction.
The h-CLAT testmethod addresses KE-3 of the skin sensitisation AOP
by quantifying changes in the expression of cell surface markers associ-
ated with the process of activation of monocytes and dendritic cells
(DC), i.e. CD86 and CD54, in the human monocytic leukaemia cell line
THP-1 following 24 hour exposure to eight serial concentrations of the
test chemical. The h-CLAT readouts included in the dataset were: a)
the CV75, i.e. the test chemical concentration resulting in 75% cell viabil-
ity compared to the solvent/vehicle control; b) two binary descriptors
indicating whether the cell surface markers (CD86 and CD54) were
expressed; c) the EC150 and EC200 values corresponding to the concen-
trations at which the test chemicals induces a relative ﬂuorescence in-
tensity (RFI) equal or above 150% for the CD86 and equal or above
200% for the CD54; and d) the h-CLAT positive or negative prediction.
Data from in chemico and in vitro tests were double checked and up-
dated with the latest results provided by the test developers.When dis-
crepancies between different sources of data for the same chemical
were found, the test developers were contacted for clariﬁcation and a
ﬁnal call was made on the basis of the quality of data and the precau-
tionary principle. When data from validation studies was available for
a chemical, it was preferred over any other source since it is considered
of higher quality because it was generated under blind testing
conditions.
A number of chemicals were tested in the in chemico and in vitro
methods with slightly different formulations, e.g. sulphate vs. disulphate,
aldehyde vs.hydro aldehyde, sulphate heptahydrate vs. sulphate, racemic
mixtures vs. pure enantiomers, etc. These variations in the formulations
are not expected to affect chemical reactivity or hazard classiﬁcation
because they do not represent modiﬁcations of the reactive part of the
molecule. These formulations were merged into single entries in order
to have a larger number of chemicals with complete data, i.e. data from
all in chemico and in vitro methods. In some cases, chemicals with the
same name and different CAS numbers were found in different sources.
These data were also merged into single entries. Table 1 shows the
chemicals thatwere found in different sourceswith different formulation,
name, and/or CAS number; and that were merged into single entries.
2.3. In silico descriptors
The dataset of 269 chemicals was complemented with in silico de-
scriptors generated with various software packages: the OECD QSAR
ToolBox (OECD, 2013), Derek Nexus (LHASA, 2015), Toxtree
(Ideaconsult Ltd. on behalf of the JRC, 2005), Dragon (Talete Srl,
2010), Vega (Istituto di Ricerche Farmacologiche Mario Negri, 2013),
TIMES (Dimitrov et al., 2005b), and ADMET Predictor (Simulations
Plus, Inc., Lancaster, 2014).
- OECD Toolbox (v. 3.2): the results of the chemical proﬁlers were
transformed into binary descriptors indicating the presence or
absence of each alert of each proﬁle. All proﬁlers were used. Nome-
tabolism was considered when processing the chemicals.- Vega (v. 1.0.8): all Vega modules (e.g.mutagenicity, skin sensitisa-
tion, Daphnia magna LC50, BCF Read-Across, and LogP) were run
and the results were used as descriptors.
- Toxtree (v. 2.6.6): all modules (e.g. Amesmutagenicity, carcinogenic-
ity, Cyp450, DNA binding, skin sensitisation) were run and the re-
sults were used as descriptors.
- Derek Nexus (v. 1.7.6 (4.0.6)): the predictions obtained for skin and
respiratory sensitisation, skin and eye irritation, and
photoallergenicity for human, mammal, mouse, and rat were used
as descriptors.
- ADMET (v. 7.1): the results obtained from the physicochemical, bio-
pharmaceutical, and toxicity modules were used as descriptors.
- TIMES-SS (v. 2.27.13): the results of models of different endpoints
like Daphnia magna 24 h EC50, Vibrio ﬁscheri 5 min, phototoxicity,
estrogen receptor, Ames mutagenicity, and skin sensitisation, were
used as descriptors. The last three endpoints also included the me-
tabolism simulator with autoxidation. All the predictions were car-
ried out using the default setting that includes a conformer
optimisation step.
- Dragon (v. 6.0.7): All descriptors were calculated and the highly cor-
related (N0.95) and invariant ones were ﬁltered out.
The descriptors listed abovewere calculated from the SMILES codes of
the chemicals, whichwere preferably obtained from the data sources, and
when not provided, from Chemspider (www.chemspider.com), Sigma-
Aldrich, or PubChem by using as queries the names and CAS numbers
found in the sources. The 3D structures needed by Dragon to calculate
3D descriptors were generated from the SMILES codes of the chemicals
using the Open Babel (O'Boyle et al., 2011) node implemented in KNIME
(Berthold et al., 2007). The SMILES codes that were used for the calcula-
tions did not include salts as they were stripped. A ﬁnal dataset of 269
chemicals with about 4500 descriptors for each chemical was obtained
by combining the in silico descriptorswith the in chemico and in vitro data.
2.4. Subsets of data
Due to the different number of chemicals with available in chemico
and/or in vitro data, ﬁve different subsets of the entire dataset were
used for modelling. The ﬁrst subset, “complete subset”, consisted of
127 chemicals with DPRA, KeratinoSens™, h-CLAT data, and in silico
200 D. Asturiol et al. / Toxicology in Vitro 36 (2016) 197–209predictions. The second subset, “DPRA subset”, consisted of 167
chemicals with DPRA data and in silico predictions. The third subset,
“KeratinoSens™ subset”, consisted of 223 chemicals with KeratinoSens
™ data and in silico predictions. The fourth subset, “h-CLAT subset”,
consisted of 168 chemicals with h-CLAT data and in silico predictions.
The ﬁfth subset, “in silico subset” consisted of 269 chemicals with in
silico predictions only. The training and test sets of each subset were
generated using the procedure explained next.
2.5. Data split
80% of the skin sensitisation subsets were used as training sets, or
modelling sets, and 20% as external test sets, or validation sets. The
chemicals were structurally diversely picked in order to maximise the
overlap between the two sets and increase the chances that themodels
obtained with the training set could be successfully applied to the vali-
dation set (Tong et al., 2003). The procedure was carried out separately
for sensitisers and non-sensitisers to have a better representation of
both groups. The proportion of sensitisers and non-sensitisers was
kept as given in the subsets to maximise the number of chemicals
used for modelling and to improve the prediction of sensitisers, i.e. re-
duce the number of false negatives (FN) as sensitiserswere represented
in larger proportions in the subsets. In practice, the training and test sets
were deﬁned as depicted in Fig. 1.
The chemicals were ﬁrst divided between sensitisers (S) and non-
sensitisers (NS) according to their LLNA results. Fingerprints accounting
for structural descriptors were calculated using the RDKit ﬁngerprints
node (Landrum, 2015) in a KNIME workﬂow. A principal component
analysis (PCA) on the Tanimoto similarity matrix was carried out and
the components accounting for 90% of the variability were kept. This
step was carried separately for S and NS. The remaining components
were used to cluster the chemicals using the k-Means algorithm imple-
mented in KNIME in asmany clusters as the number of chemicals divid-
ed by 10 and 5 for sensitisers and non-sensitisers, respectively. In the
ﬁnal step, 80% of the chemicals of each cluster were assigned to the
training set using a stratiﬁed random selection algorithm, and the rest
of chemicals were assigned to the test set (Fig. 1).
2.6. Generation of classiﬁcation trees (CT)
Machine learning methods generate better performing models
when datasets with smaller number of descriptors are used (Witten
and Frank, 2005). In order to reduce the number of descriptors, i.e. re-
duce the dataset dimensionality, feature selection methods like classiﬁ-
er subset evaluation, correlation based subset evaluation (Hall, 1998), or
information gain attribute evaluation, combined with different search
algorithms like genetic algorithm (Goldberg, 1989), ranking and best
ﬁrst, were applied to the training sets. Various lower-dimensional sets
of the subsets of data mentioned above were obtained after applying
different feature selection methods, and these lower-dimensional sets
were used to build CTs. All CTs were generated with the Weka (Hall etDataset
Sensitisers Calculate 
structural
descriptors 
(Fingerprints)
PCA o
similarity 
(90% varia
Calculate 
structural
descriptors 
(Fingerprints)
PCA o
similarity 
(90% varia
Non
Sensitisers
Fig. 1. Data split procedure applied to the skin sensitisation subsets of data. The similarity m
implemented in KNIME.al., 2009) node implemented in KNIME using the C4.5 algorithm
(Salzberg, 1994). The treeswere generated using thedefault parameters
except the minimum number of components per leaf, which was in-
creased from2 to 8 for the in silico dataset and to 5 for the other datasets
containing in vitro/in chemico descriptors.
3. Results
3.1. Most discriminating descriptor
All CTs obtainedwith the various subsets of data selected the TIMES-
SS protein adduct formation descriptor (hereafter TIMES-ProtBind) as
ﬁrst and most discriminating descriptor. This descriptor represents a
prediction of the amount (in moles) of test chemical that would cova-
lently bind to a mole of protein and is named “AmountAduct/mol/” in
TIMES-SS outputs. TIMES-ProtBind not only considers the parent chem-
ical reactions but also the reactions of its possible metabolites and au-
toxidation products, which are generated by the skin metabolism
simulator implemented in TIMES-SS. Thus, TIMES-ProtBind addresses
theMIE of the AOP and accounts for both biotic and abiotic transforma-
tions. Surprisingly, other descriptors that also account for the MIE and
thatwere present in the datasets, i.e.DPRA cysteine and/or lysine deple-
tion values or evenKeratinoSens™ readouts,were never selected asﬁrst
nodes if TIMES-ProtBind was present in the training set. This is due to
the fact that the algorithm that we used to build the classiﬁcation
trees (C4.5) selects the descriptor with the highest information gain
ratio as ﬁrst node. This descriptor corresponds to TIMES-ProtBind for
all datasets as is shown in Figs. SI4–SI8.
In order to investigate further the reason why TIMES-ProtBind was
always preferred to in chemico or in vitro readouts as ﬁrst decision
node in the CTs, the predictions of TIMES-ProtBind, DPRA, and
KeratinoSens™ were compared and the results are presented in Fig. 2.
Pie chart B informs about the discrepancies in predictions between
DPRA and TIMES-ProtBind by representing chemicals (n= 26) predict-
ed as negative by the DPRA and positive by TIMES-ProtBind. The largest
proportion of these chemicals are nevertheless positive in the LLNA (18
in the 1B and 3 in the 1A skin sensitisation GHS subcategories, pink and
red sectors of the pie, respectively) and are therefore false negative
(FNs) in the DPRA but are correctly predicted as true positives (TPs)
by TIMES-ProtBind. The green sector of the pie represents LLNA nega-
tive chemicals (n = 5) which are correctly predicted by DPRA, and are
false positives (FPs) in TIMES-ProtBind. Pie chart D provides the same
kind of information when comparing KeratinoSens™ with TIMES-
ProtBind results. Pie charts E and G represent chemicals the vast major-
ity of which are correctly predicted as TNs by TIMES-ProtBind but are
FPs in both DPRA (pie chart E) and KeratinoSens™ (pie chart G). The
last row of Fig. 2 shows the results of TIMES-ProtBind predictions for
the chemicals for which DPRA (pie charts I and J) and KeratinoSens™
(pie charts K and L) data was not available.
In general it is observed that TIMES-ProtBind correctly predicts
around 80% of the chemicals that are mispredicted by the in chemico/n 
matrix 
bility)
k-Means 
clustered
n 
matrix 
bility)
k-Means 
clustered
Randomly 
selected 
(stratified)
Randomly 
selected 
(stratified)
Training 
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set
atrix was calculated using Tanimoto's distance. All algorithms correspond to the ones
DPRA KeratinoSensTM
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A
E
I
1A, 1 (9.1%)
1B, 1 (9.1%)
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J
C
G
K
D
H
L
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1A, 2 (4.4%)
1B, 24 (58.5%)
NS, 12 (29.3%)
1A, 12 (30.8%)
1B, 27 (69.2%)1B, 2 (28.6%)
1B, 64 (66.0%)
1A, 31 (32.0%)
NS,2 (2.0%) 
1B, 27 (48.2%)
1A, 1 (1.7%)
1A, 15 (26.8%)NS, 14 (25.0%)
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NS, 28 (82.4%)
NS, 5 (19.2%)
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NS, 9 (9.1%)
NS, 20 (87.0%)
1A, 5 (12.2%)1B, 5 (8.3%)1A, 3 (11.5%)
1B, 18 (69.2%)
1B, 3 (13.0%)
1B, 6 (17.6%)
1A, 32 (32.3%)
0
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Fig. 2. Pie charts comparing the predictions of TIMES-ProtBind vs.DPRA and KeratinoSens™when predicting LLNA skin sensitisation results. The colours of the pie charts group chemicals
by their LLNA results: green for non-sensitisers, pink for Cat 1B sensitisers, and red for Cat 1A sensitisers. The sizes of the pie charts are proportional to the number of chemicals they
contain. Each pie chart corresponds to chemicals binned by the DPRA and KeratinoSens™ skin sensitisation predictions (rows) vs. TIMES-ProtBind prediction (columns). Negative
predictions are indicated with 0 whereas positive predictions are indicated with 1. As an example, the top left pie chart (A) corresponds to the chemicals that are predicted to be non-
sensitisers by DPRA and that are predicted not to bind to proteins by TIMES-ProtBind. The larger sector of the pie shows that 82% (n = 28) of the chemicals are negative in the LLNA
(represented in green in the pies) and, therefore, are correctly predicted as true negatives (TNs) by DPRA and TIMES-ProtBind. The smaller sector of the pie corresponds to chemicals
(n = 6) with positive LLNA classiﬁcation (Cat 1B, represented in pink in the pies) which are FNs in both DPRA and TIMES-ProtBind. The same kind of information for KeratinoSens™ is
given by pie chart C.
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TIMES-ProtBind andh-CLAT are not shown since the analysis and values
are very similar to theDPRAones. However, they can be found in Fig. SI1
of the Supporting Information.
3.2. Consensus model
In order to obtain a model for skin sensitisation hazard that
provides the safest possible results for the consumers, a conserva-
tive consensus model constituted by two classiﬁcation trees, i.e. a
decision forest of two trees (Tong et al., 2003), was built. This
kind of model is characterised by having a lower number of FNs
than the individual trees that constitute them since a chemical isTIMES-
ProtBind
Dragon-
Mor32s
<=0 TIMES-SkinSens-
T.StructuralDomain
Dragon-O-
056
Dragon-
HATS4e
Dragon-
Eig08_AEA(bo)
>0
0
Dragon-SpDiam
EA(bo)
0 1 1 0 1 0 1
<=0.336
= Out of domain
>0.571>0
>6.005
>-0.031
<=6.005
<=0
= In domain
<=-0.031
<=0.571
>0.336
CT1
Fig. 3. Classiﬁcation trees with the highest speciﬁcity and accuracyclassiﬁed as non-sensitiser only when both individual trees provide
a negative prediction for that chemical. For any other combination
of results from the individual trees, i.e. discordant predictions or
concordant positive predictions, the chemical is predicted as
sensitiser.
The C4.5 algorithm was used on the lower-dimensional sets of data
that were obtained from the complete, DPRA, KeratinoSens™, h-CLAT,
and in silico subsets to generate a number of trees from which to build
the consensus model. Only trees with sensitivities and speciﬁcities
above 0.80 were considered as potential candidates for the consensus
model. The two classiﬁcation trees thatwere selected to form the consen-
sus model were those with the highest speciﬁcity and accuracy, and are
shown in Fig. 3.TIMES-
ProtBind
Dragon-Ds
<=0.0106 TIMES-SkinSens-
T.StructuralDomain
Dragon-H-
052
Dragon-
Mor24u
Dragon-HATS6i
>0.0106
0 1 1 1 0 1 0
<=0.626
= Out of domain
>0.075>0
>0.647
<=0
= In domain
<=0.647
<=0.075
>0.626
CT2
that were selected to build the conservative consensus model.
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ly on TIMES-SS and Dragon descriptors and have similar shapes. Other
trees with different types of descriptors including Vega and
KeratinoSens™ IC50 were generated but their predictive performances
were lower. CT-1 and CT-2 share the ﬁrst node, and also share the sec-
ond node that separates protein binders that fall inside and outside
the total skin sensitisation structural applicability domain of TIMES-SS
(hereafter TIMES-SkinSens-T.StructDomain). The descriptors used by
the consensus model are shown in Table 2 together with an interpreta-
tion of their function in the classiﬁcation trees.
TIMES-ProtBind is the predicted amount of test chemical that would
bind to skin protein. This quantity (mol of test chemical/mol of protein)
is obtained by the software in two simultaneous steps. The ﬁrst step is to
determine the metabolites and autoxidation products that the parent
chemical can be transformed into. This is done by the metabolism sim-
ulator which submits the test chemical and each of the predicted me-
tabolites to a set of predeﬁned possible chemical transformations that
include spontaneous reactions and enzyme catalysed biotransformation
reactions (phase I and II). In the second step, each of the generated me-
tabolites/products is given a probability to covalently bind to proteins.
The covalent reactions to proteins are described by 47 alerting groups
and are in accordance with the existing knowledge on electrophilic
mechanisms underlying skin sensitisation (Aptula et al., 2005; Enoch
et al., 2011). The ultimate probabilities of each reaction to take place
are determined by a combination of sub-models and 3D QSARs that
take into account the nature of the reactive group, sub-structural fea-
tures, steric effects, molecular size, shape, and lipophilicity among
other parameters (Dimitrov et al., 2005b). Thus, TIMES-SS ProtBind
(“TIMES AmountAduct/mol/” in the software output) accounts for
both the test chemical and its metabolites/products that covalently
bind to proteins.Table 2
List of descriptors used by the consensusmodelwith their deﬁnition and observed function in th
after the name of the descriptor.
Descriptor Description
TIMES-ProtBind (CT-1 & CT-2) Prediction of the amount of test chemical – either pare
any of the predicted metabolites or autoxidation produ
bind covalently to a mole of skin protein
TIMES-SkinSens-T.StructDomain
(CT-1 & CT-2)
It determines whether the test chemical falls in the stru
applicability domain of TIMES-SS
Mor32s (CT-1) and
Mor24u (CT-2)
3D MoRSE descriptors (3D Molecule Representation of
based on Electron diffraction) are derived from infrared
simulation using a generalised scattering function. Mor
corresponds to signal 32 weighted by I-state, and Mor2
un-weighted signal 24.
SpDiam_EA(bo) (CT-1)
and Eig08_AEA(bo) (CT-1)
Spectral diameter from edge adjacency matrix weighte
order
Eighth eigenvalue of the augmented edge adjacency m
by bond order
O-056 (CT-1) Presence of alcohol (−OH) groups
HATS4e (CT-1)
and
HATS6i (CT-2)
The GETAWAY (GEometry, Topology, and Atom-Weigh
descriptors are molecular descriptors derived from the
Inﬂuence Matrix (MIM). HATS4e is a leverage-weighted
autocorrelation of lag 4 weighted by Sanderson electro
HATS6i is a leverage-weighted autocorrelation of lag 6
ionization potential
Ds (CT-2) D total accessibility index weighted by I-state. It is built
as to capture relevant molecular 3D information regard
molecular size, shape, symmetry, and atom distribution
to invariant reference frames. It increases when the var
distribution of the electrotopological charges is relevan
presence of electronegative groups at one end of the m
(Todeschini and Gramatica, 1997; Todeschini et al., 199
H-052 (CT-2) H attached to C(sp3) with 1 heteroatom attached to thTIMES Skin Sensitisation Total Structural Domain (TIMES-SkinSens-
T.StructDomain) is a binary descriptor provided by TIMES-SS determin-
ingwhether the test chemicals fall in the structural applicability domain
of TIMES-SS. This descriptor is the result of the combination of three
measures:
a) percentage of atom-centred fragments of test chemical correspond-
ing to fragments extracted only from training set chemicals correctly
predicted by the model
b) percentage of atom-centred fragments of test chemical correspond-
ing to fragments extracted only from training set chemicals incor-
rectly predicted by the model
c) percentage of atom-centred fragments of test chemical not found in
training set chemicals of the model
TIMES-SkinSens-T.StructDomain only considers test chemicals “In
domain” if 100% of the atom-centred fragments of the test chemical cor-
respond to fragments found in training set chemicals correctly predict-
ed by the model, i.e. if all the fragments fall in measure a) above. Test
chemicals with any other combination are considered “Out of domain”.
The other descriptors used in the consensus model correspond to
Dragon descriptors (see Table 2). Of these, O-056 and H-052 are easily
interpretable. They are used as binary descriptors indicating the pres-
ence of OH– groups and the presence of a hydrogen atom attached to
a sp3 carbon with a heteroatom attached to the next carbon atom, re-
spectively. The rest of the descriptors account for structural features
and are derived from molecular inﬂuence matrixes, spectra, edge adja-
cent matrix, or the Cartesian coordinates of the atoms. Some of them
are weighted by electronic properties of the molecules like electroneg-
ativity, ionization potential, or levels of electronic states. Of the othere individual trees. The tree inwhich each of the descriptors is used is indicated in brackets
Chemical/functional interpretation
nt chemical or
cts – that will
Distinguishes protein binders from non-binders
ctural Distinguishes chemicals whose all atom-centred fragments are
found within the correctly predicted chemicals of the training
set of TIMES, from others
Structures
spectra
32s
4u to the
Distinguish large and long molecules like Kanamycin or sodium
lauryl sulphate from phenol and benzoate like molecules
d by bond
atrix weighted
Distinguish molecules with multiple carboxylic bonds and esters
with long aliphatic chains from other molecules with no double
bonds or with shorter side chains
Distinguishes molecules containing alcohol groups
ts AssemblY)
Molecular
negativity, and
weighted by
Distinguish molecules that contain highly electrophilic groups like
cyano-, nitro(so)-, or halo-substituents, from others with less
electrophilic groups like alcohol and amines. HATS6i distinguishes
acrylates and sulphates from other molecules
in such a way
ing the
with respect
iability of the
t. Indicates the
olecule
4).
Distinguishes nitro benzenes from other molecules (predicted
non-reactive to proteins)
e next C Distinguishes saturated molecules from unsaturated
203D. Asturiol et al. / Toxicology in Vitro 36 (2016) 197–209descriptors, Ds is a directional weighted holistic invariant molecular de-
scriptor (Todeschini and Gramatica, 1997) and is larger for molecules
that have regions of high density of mass or electronegativity. Thus, it
can indicate the presence of nitro, tri-ﬂuoro, carbonyl, or halogen
groups at one end of a molecule. In our model, Ds separates nitro ben-
zenes (that were predicted non-reactive to proteins) from other mole-
cules. Mor32s and Mor24u are 3D molecule representations of
structures based on electron diffraction. Their interpretation is not
straightforward and in general indicate the presence of pairs of atoms
beyond a certain distance (Devinyak et al., 2014). In our model, they
seem to separate large and long molecules like Kanamycin or sodium
lauryl sulphate from phenol and benzoate like molecules, all of them
predicted non-reactive to proteins. HATS4e and HATS6i are geometry,
topology, and atom-weights assembly (GETAWAY) descriptors
(Consonni et al., 2002a). These descriptors try to match 3D molecular
geometry with chemical information by using Sanderson electronega-
tivity and ionization potential as atomic weightings, respectively. At
the practical level, they encode local information related to molecular
fragments and substituent groups (Consonni et al., 2002b). In our
model they separate molecules that contain highly electrophilic groups
like cyano-, nitro(so)-, or halo-substituents, from less electrophilic
groups like alcohol and amines. HATS6i determines the skin sensitisa-
tion prediction for many acrylates and sulphates too. SpDiam_EA(bo)
and Eig08_AEA(bo) are descriptors derived from graph-theorymatrices
(Janežič et al., 2007), which are molecular graphs accounting for the 2D
structure of molecules by indicating the atoms or chemical bonds that
are adjacent to each other (adjacency matrices). SpDiam and Eig08 are
properties of such matrices. SpDiam stands for spectral diameter and
is calculated as the difference between the largest and smallest matrix
eigenvalue of the matrix, and Eig08 is the eighth eigenvalue of the ma-
trix. SpDiam_EA(bo) is, thus, the spectral diameter of the edge adjacen-
cy matrix, i.e. the diameter of the matrix that indicates the adjacency of
edges (chemical bonds) of amolecule,weighted by thebondorder. Sim-
ilarly, Eig08_AEA(bo) is the eighth eigenvalue of the augmented edge
adjacency matrix weighted by bond order. The augmented edge adja-
cencymatrix is a variation of the adjacencymatrix that is used to differ-
entiate between bond types by giving them different weights. In our
model, these descriptors separate molecules with multiple carboxylic
bonds and esters with long aliphatic chains from other molecules with
no double bonds or shorter chains.
3.3. Applicability domain
The applicability domain (AD) of the consensusmodel is determined
by the applicability domain of the individual trees and is shown in Figs.
SI2 and SI3 of the Supporting Information. The AD of each tree was
determined from the correctly predicted chemicals of the correspond-
ing training sets (Tong et al., 2005) as the range of values expanded
by the descriptors used in CT-1 and CT-2± 15%. Following this strategy,
theAD of TIMES-ProtBindwas set to values between 0 and 2.30. This de-
scriptor is a quantitative value indicating the moles of test chemical ca-
pable of binding to proteins and, in our model, is used as a binaryTable 3
Predictive performance (Cooper statistics) of CT-1 and CT-2 vs. LLNA, and of the consensus mod
sets are shown separately. CT-1 and CT-2 have different number of chemicals as they were der
chemicals) and CT-2 from the in silico subset (269 chemicals). External Test Set consists of the
Model Subset TP TN FP FN
Consensus model vs. LLNA 166 84 15 4
vs. Human 57 23 13 6
CT1 Training (80%) 99 71 4 2
Test (20%) 23 16 3 4
External test 34 5 0 8
CT2 Training (80%) 125 72 6 9
Test (20%) 29 18 3 7
LLNA vs. Human 58 21 15 5descriptor indicating whether a molecule will bind to proteins. Thus,
strictly speaking this descriptor should have no upper limit as the
model will also correctly predict chemicals with more reactive groups.
For obvious reasons, such a descriptor cannot have negative values. A
similar situation is found for Dragon-O-056 and Dragon-H-052 as they
account for the presence of structural features.
TIMES predictions are also subject to their own applicability domain
(Dimitrov et al., 2005a), which is derived from 3 sub-applicability do-
mains, i.e. general parametric domain, structural domain, and interpola-
tion space domain. In the development of the consensus model all the
predictions provided by TIMES were considered valid as suggested by
the developers (Jaworska et al., 2015), but each AD was included in
the pool of descriptors. TIMES-SkinSens-T.StructDomain was ﬁnally se-
lected by the algorithm to form CT-1 and CT-2, and obviously its values
are limited to “In domain” and “Out of domain”.
Three chemicals, Dextran, dimethyl formamide, and ﬂuorescein-5-
isothiocyanate seem to fall outside the ADof CT-1 in Fig. SI2 (Supporting
Information). This is the case for the global domain but not for the fo-
cused domain, i.e. the domain deﬁned by only those descriptors used
to derive the prediction of these chemicals (Tong et al., 2005). Dextran
falls outside the AD of Dragon-O-056, but its prediction is derived
fromDragon-HATS4e. Dimethyl formamide falls outside theADof Drag-
on-HATS4e but is predicted through Dragon-Mor32s and Dragon-
SpDiam_EA(bo). Similarly, ﬂuorescein-5-isothiocyanate falls outside
the AD of Dragon-Mor32s but its prediction is derived from Dragon-O-
056. Thus, the predictions of chemicals falling outside the global domain
should not be affected if they fall in the focused domain.
3.4. Predictive performance of the consensus model
The predictive performances of the consensusmodel and of the indi-
vidual trees are shown in Table 3. Common Cooper statistic measures
(i.e. accuracy, sensitivity, and speciﬁcity) and the number of true posi-
tives (TP), true negatives (TN), false positives (FP), and false negatives
(FN) for the training and test sets are provided (Cooper et al., 1979). Bal-
anced performance values (prevalence independent) are not reported
as they are very similar to the Cooper ones.
The accuracy and sensitivity of the consensus model for predicting
LLNA classiﬁcations (positive/negative) for a total of 269 chemicals are
0.93 and 0.98, respectively. The high sensitivity achieved is the result
of using the conservative consensus approach, which boosts sensitivity
at expense of speciﬁcity, which is reduced to 0.85 with respect to those
of the individual trees (Table 3). Even though the objective of this work
was not to predict human skin sensitisation, the performance of the
consensusmodel that results fromusing thehuman sensitisation poten-
tial present in our dataset (Basketter et al., 2014) as reference was
added for comparison. The performance of the LLNA in predicting
human skin sensitisation was also added for comparison. Both the con-
sensus model and LLNA predict human skin sensitisation potential al-
most identically, with an accuracy of 0.80–0.81, sensitivity of 0.90–
0.92, and speciﬁcity 0.58–0.64 for a total of 99 chemicals. Regarding
the performance of the individual trees that constitute the consensusel vs. LLNA and human data (Basketter et al., 2014). Performances for the training and test
ived from different subsets of data. CT-1 was derived from the KeratinoSens™ subset (223
chemicals that were not tested with KeratinoSens™.
Accuracy Sensitivity (TP/TP + FN) Speciﬁcity (TN / TN + FP)
0.93 0.98 0.85
0.81 0.90 0.64
0.97 0.98 0.95
0.85 0.85 0.84
0.83 0.81 1.00
0.93 0.93 0.92
0.82 0.81 0.86
0.80 0.92 0.58
Table 4
List of FN results of the consensus model with respect to the LLNA.
Chemical Name TIMES-ProtBind Rationale and notes
Hexyl salicylate 0
No alerts for reactivity. It is an irritant. It has
been suggested (Urbisch et al., 2015) as possible
FP in the LLNA. Additionally, h-CLAT data shows
it is positive for CD54 activation, only.
Pyridine 0
No alerts for reactivity. It has been suggested
(Urbisch et al., 2015) as possible FP in the
LLNA. Additionally, h-CLAT data shows it is
positive for CD86 activation only, with very
high CV75 and EC150(CD86).
Xylene 0
No alerts for reactivity. It has been suggested
(Urbisch et al., 2015) as possible FP in the
LLNA. It is also negative in all in vitromethods.
Tocopherol 0.16
Predicted by TIMES to have metabolites that
react with proteins. It falls outside Total
Structural Domain of TIMES. It is a NS in
humans and, therefore, a FP in the LLNA
(Urbisch et al., 2015).
Table 5
List of FP predictions of the consensus model with respect to LLNA classiﬁcations. The
values obtained for TIMES-ProtBind and the individual CT-1 and CT-2 predictions are also
included.
Chemical Name TIMES-ProtBind CT-1
Prediction
CT-2
Prediction
1-Chloro-2-methyl-3-nitrobenzene 0 0 1
1-Iodohexane 0.93 1 0
1-Methoxy-4-methyl-2-nitrobenzene 0.29 0 1
1-Octen-3-yl acetate 1.44 1 0
2-Mercaptobenzoxazole 0.75 0 1
2-Nitro-3-pyridinol 0 0 1
3-Hydroxy-4-nitrobenzoic acid 0 0 1
Dihydromyrcenol 0.31 1 0
Ethyl benzoylacetate 0.46 1 0
Geranyl nitrile 0.74 1 1
Hydrocortisone 0.24 0 1
N-p-Benzonitrile
menthanecarboxamide
0.93 0 1
p-Nitro-benzaldehyde 0.07 1 0
Saccharin 0.58 1 0
Sodium 1-nonanesulfonate 0 0 1
204 D. Asturiol et al. / Toxicology in Vitro 36 (2016) 197–209model, i.e. CT-1 and CT-2, they show accuracies, sensitivities and speci-
ﬁcities above 0.90 for the training sets and above 0.82, 0.81 and 0.84 for
the test sets. The performance for the external test set, i.e. the chemicals
not included in the KeratinoSens™ subset, is also similar but with no
FPs. These values show that the performances of the consensus model
for the training and test sets of CT-1 and CT-2 are similar and above
0.82, which indicates that the models are robust and not overﬁtted.3.5. Mispredictions
Table 3 shows that the consensus model predicts 88 chemicals as
negative (non-sensitisers) and that 84 of these correspond to chemicalsTable 6
Summary of the results of the consensus model with respect to the LLNA classiﬁcations binn
SkinSens-T.StructDomain.
Binning
Result
vs.
LLNA
Concordant CT-1 & CT-2 Discordant
CT-1 & CT-2
TP 144 22
FP 1 14
TN 84 –
FN 4 –classiﬁed as non-sensitisers by the LLNA. The other 4 predictions are FNs
and correspond to hexyl salicylate, pyridine, xylene, and tocopherol.
They are listed in Table 4 together with the possible reasons for the
misprediction and additional considerations. TIMES-ProtBind values
are also listed.
Hexyl salicylate, pyridine, and xylene do not have chemical features
that indicate that they are reactive, and they are predicted to be non-re-
active to proteins by TIMES. This is supported by the fact that the three
chemicals are negative in the DPRA and KeratinoSens™, and xylene is
also negative in the h-CLAT assay. Therefore, most certainly neither
these compounds nor their metabolites/products are reactive to pro-
teins. Xylene is a well-known FP in the LLNA, hexyl salicylate is a
known irritant (which is a confounding factor in the LLNA and may
give FPs results), and pyridine is positive for only one of the markers
measured in h-CLAT (i.e. CD54) but at very high cytotoxic concentration.
Thus, evidence suggests that the three chemicals might be FPs in the
LLNA. This possibility is in agreement with other works (Basketter et
al., 2014; Urbisch et al., 2015).
The other compound, tocopherol, is also a FP in the LLNA and is neg-
ative in h-CLAT. However, it is predicted to be reactive to proteins by
TIMES although it falls outside the total structural domain of TIMES. Nei-
ther Dragon-HATS4e nor Dragon-Mor24u is able to ﬁx the TIMES-
ProtBind prediction and render tocopherol as sensitiser. The reason for
this is probably the fact that it falls in the “weak part” of the model,
which will be explained next.
Table 3 shows that of the 181 positive predictions generated by the
consensus model, 166 of them correspond to chemicals classiﬁed as
sensitisers by the LLNA. Thus, the 15 remaining chemicals are FPs of
the consensus model and are listed in Table 5 with TIMES-ProtBind
values and with the CT-1 and CT-2 individual predictions. The reason
for including the individual predictions of CT-1 and CT-2 is to show
that neither is systematically over-predicting sensitisers, but that the
misclassiﬁcations are attributable to both trees in very similar propor-
tion with 6 and 8 misclassiﬁcations, respectively. Of the FPs, only
geranyl nitrile is predicted as sensitiser by both trees.
Table 5 shows that most FPs of the consensus model correspond to
discordant predictions of CT-1 and CT-2. In fact, 14 out of 15 FPs of the
consensus model correspond to discrepancies between CT-1 and CT-2
(see Table 6). However, when the predictions of CT-1 and CT-2 are con-
cordant the probability of being a TP or TN is very high. 145 chemicals in
our dataset correspond to CT-1 and CT-2 positive concordant predic-
tions and only 1 of these is a FP. If we would only consider concordant
predictions from CT-1 and CT-2 as valid outputs of our model (i.e.
pure consensus), the predictive performance would be: accuracy =
0.98, sensitivity = 0.97, and speciﬁcity = 0.99. However, this would
alsomean that only 87% of the chemicals of our dataset could be predict-
ed (coverage = 87%) as the rest (13%) would correspond to
contradictive outputs of CT-1 and CT-2, which are considered equivocal
in pure consensus models.
Besides the discordance between CT-1 and CT-2 predictions, TIMES-
SS predictions also play an important role in themispredictions. Consid-
ering the 15 FPs generated by the consensus model, 11 are predicted by
TIMES-ProtBind to be reactive to proteins and 8 of these are considereded by the individual predictions of CT-1 and CT-2, values of TIMES-ProtBind, and TIMES-
Positive TIMES-ProtBind
&
outside TIMES-SkinSens-T.StructDomain
Negative Consensus model
&
Positive TIMES-ProtBind
15 –
8 –
7 11
1 1
205D. Asturiol et al. / Toxicology in Vitro 36 (2016) 197–209outside the applicability domain of TIMES. There are 31 chemicals in our
dataset that are predicted positive by TIMES-ProtBind and that fall out-
side the structural skin sensitisation applicability domain of TIMES (see
3rd column of Table 6). A lower predictive performance for these
chemicals is observed, i.e. only 71% of these 31 chemicals are properly
predicted by the consensus model since the predictions turn out to be
7 TN, 15 TP, 8 FP, and 1 FN with respect to the LLNA classiﬁcations.
The FN prediction corresponds to tocopherol (see Table 4). The fact
that the chemicals are predicted to bind to proteins by TIMES and are
predicted as non-sensitisers by the consensus model is not a source of
concern because this combination takes place for 12 substances and
there is only one chemical misclassiﬁed, tocopherol (see 4th column
of Table 6).
Predictions with concordant results from CT-1 and CT-2 have much
higher conﬁdence than those that are not concordant. In order to pro-
vide more accurate prediction conﬁdences, we have analysed the con-
sensus model predictions with respect to the combinations of CT-1
and CT-2 in more detail and have assigned to each prediction a qualita-
tive conﬁdence value, i.e. very high, high, low, or very low, depending on
the combination of leaves used in CT-1 and CT-2. The qualitative conﬁ-
dence measures are based on the percentage of correct predictions ob-
tained by each combination of leaves. The qualitative conﬁdence
measures for each combination of CT-1 and CT-2 with the correspond-
ing PPV and NPV obtained for our dataset are provided in Table 7.
Concordant positive predictions of CT-1 and CT-2 have a high rate of
TPs, 144 out of 145. Therefore concordant positive predictions of CT-1
and CT-2 are assigned a very high conﬁdence. Table 6 also shows that
only 61% of the discordant positive predictions correspond to TPs and
that, therefore, discordant positive predictions should correspond to
low conﬁdence predictions. Table 7 shows that this is the case for the
majority of discordant predictions between CT-1 and CT-2, but there
are some combinations for which the rate of TPs is very high. For in-
stance, 4 out of 4 predictions based on positive CT-1 obtained from
Dragon-SpDiam_EA(bo), and negative CT-2 obtained from Dragon-Ds,
correspond to TPs. Thus, predictions obtained from this combination
are considered highly reliable even though they correspond to discor-
dant outputs of CT-1 and CT-2. The combination of positive CT-1 via
Dragon-HATS4e and negative CT-2 via Dragon-Mor24u correctly pre-
dicts as sensitiser only 1 out of 4 chemicals. Consequently, predictions
obtained with this combination are considered of very low conﬁdence.
The conservative consensus model was built to improve sensitivity
and, as shown in Table 6, negative predictions are highly reliable. How-
ever, Table 7 shows that the combination of (negative) Dragon-HATS4e
and Dragon-Mor24u is not as good as the combination of other descrip-
tors since only 5 out of 6 (~83%) of the chemicals are TNs. Thus, a slightly
lower degree of conﬁdence (high conﬁdence instead of very high) was
assigned to this combination, which also corresponds to a negative pre-
diction by the consensus model but positive TIMES-ProtBind and out-
side the structural domain of TIMES (4th column of Table 6).Table 7
List of qualitative conﬁdence factors assigned to the predictions of the conservative consensus
occurred for 4 or more chemicals are shown. The corresponding PPV and NPV are also provide
Consensus Prediction CT-1 vs. CT-2 CT-1
Leaf Pre
S Concordant
S Discordant
S Discordant Dragon-SpDiam_EA(bo) 1
S Discordant Dragon-O-056 1
S Discordant Dragon-HATS4e 0
S Discordant Dragon-Mor32s 0
S Discordant Dragon-HATS4e 1
NS Concordant
NS Concordant Dragon-Mor32s 0
NS Concordant Dragon-SpDiam_EA(bo) 0
NS Concordant Dragon-Eig08_AEA(bo) 0
NS Concordant Dragon-HATS4e 04. Discussion
A dataset of 269 chemicals with high quality DPRA, KeratinoSens™,
and h-CLAT data was built. The number of chemicals in the dataset
with in vitro data lies in between those reported in Urbisch et al.
(Urbisch et al., 2015; n = 202) and Natsch et al. (Natsch et al., 2015;
n = 312), which are the largest datasets published to date although
the latter does not contain h-CLAT data. Our datasetwas complemented
with in silico descriptors from different software packages (e.g. TIMES-
SS, ADMET Predictor, Derek Nexus, The OECD Toolbox, Vega, and Drag-
on). The datasetwas used to derive amodel for skin sensitisation hazard
prediction.
The results obtained with our dataset show that in silico descriptors
are better predictors of skin sensitisation hazard than in chemico and in
vitro methods/readouts. Out of about 4500 descriptors present in our
initial dataset, the most discriminating one was TIMES-ProtBind (see
Figs. SI4–SI8 in the Supporting Information), an in silico descriptor that
accounts for the protein binding of the test chemical and their predicted
metabolites and autoxidation products, which are generated by an au-
toxidation and skin metabolism simulator (Dimitrov et al., 2005b).
Other works (Jaworska et al., 2013; Natsch et al., 2009; Patlewicz et
al., 2014) have also used TIMES-SS but instead of using its skin sensitisa-
tion predictions or alerts (Jaworska et al., 2015; Urbisch et al., 2015), our
model uses the amount of hapten-protein formation, named
“AmountAduct/mol/” in the software output, to whichwe have referred
throughout the presentmanuscript as TIMES-ProtBind. The adequacy of
such a descriptor is two-fold: it is consistent with the skin sensitisation
AOP by addressing the MIE and it provides the consensus model with a
highly mechanistic relevance as TIMES-ProtBind is mainly derived from
structural alerts that relate to chemical reactions relevant for skin sensi-
tisation that were deﬁned by experts and that are encoded in TIMES-SS.
We compared the predictions of TIMES-ProtBind in predicting LLNA
classiﬁcations with the ones of the in vitro and in chemico methods
(see Fig. 2 and Fig. SI1 in the Supporting Information). It is shown that
TIMES-ProtBind correctly predicts about 80% of the chemicals
mispredicted by the in vitro and in chemicomethods.
Apart from TIMES-ProtBind, our model also uses TIMES-SkinSens-
T.StructDomain as a descriptor. This measure of structural domain of
TIMES is very restrictive. In order to be considered in the structural do-
main of TIMES, a test chemical needs to have 100% of the atom-centred
fragments in the set of chemicals of the training set of TIMES that were
correctly predicted for skin sensitisation. In fact, the developer recom-
mended other researchers to use TIMES-SS predictions independently
of whether the chemical of interest was considered in the domain of
TIMES(Jaworska et al., 2015). Thus, given that TIMES-ProtBind has a
highlymechanistic character and that the applicability domainmeasure
of TIMES is very restrictive, we considered all TIMES predictions valid
and included the different applicability domainmeasures as descriptors
in our dataset.model depending on the leaves used in the individual trees. Only the combinations that
d.
CT-2 Conf. PPV or NPV
(%)
d. Leaf Pred.
Very high 144/145 = 99%
Low 22/36 = 61%
Dragon-Ds 0 Very high 4/4 = 100%
Dragon-HATS6i 0 Low 5/8 = 63%
Dragon-Mor24u 1 Very low 4/8 = 50%
Dragon-Ds 1 Very low 3/6 = 50%
Dragon-Mor24u 0 Very low 1/4 = 25%
Very high 84/88 = 96%
Dragon-Ds 0 Very high 67/70 = 96%
Dragon-Ds 0 Very high 6/6 = 100%
Dragon-HATS6i 0 Very high 4/4 = 100%
Dragon-Mor24u 0 High 5/6 = 83%
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in a skin sensitisation prediction model is that the model could be
overﬁtted due to a possible overlap between the training set of TIMES
and the dataset. This is not the case for our consensus model. Although
about 66% of the chemicals in our database are found in the training set
of TIMES, the accuracy of the individual trees of the consensus model in
predicting skin sensitisation hazard is similar (~0.90) for the chemicals
that belong to the training set of TIMES and those that do not (see Table
SI1), indicating that the consensus model is not overﬁtted by the use of
TIMES-SS results as descriptors.
The division of the dataset into smaller subsets of data (i.e. complete,
DPRA, KeratinoSens™, h-CLAT, and in silico subsets)was intended to ob-
tain classiﬁcation trees composed of in vitro/in chemico and in silico de-
scriptors. Surprisingly, in the very few cases in which such a
combination was obtained, the models turned out to have lower speci-
ﬁcities and accuracies. This is mainly due to the higher discriminating
power of TIMES-ProtBind, and also to the fact that TIMES-ProtBind pre-
dictions largely overlap with the predictions of the different in vitro
methods (see Fig. 2), what prevents them from being included into
the tree once TIMES-ProtBind is selected. Classiﬁcation trees with
DPRA, KeratinoSens™, and h-CLAT descriptors were obtained when
TIMES-ProtBind was manually removed from the pool of descriptors,
but in all cases the Cooper statistics of the resulting classiﬁcation trees
were signiﬁcantly lower. This shows that if any experimental method
is capable of predicting protein binding similarly to TIMES (perhaps in-
cluding an efﬁcient metabolic system) TIMES-ProtBind could probably
be substituted in our model.
We aimed at providing a model with the lowest reasonable number
of FNs (highest sensitivity) since, besides the obvious safety and ethical
reasons, such a model would have the potential to be used as a screen-
ing tool by different stakeholders like regulators and industry. A model
that predicts non-sensitisers with high conﬁdence can be used to gain
assurance before releasing products to the market, to detect substances
of high concern, or even in a 2-tiered approach to predict skin sensitisa-
tion potency.We achieved a predictivemodel with very high sensitivity
and accuracy by combining the two classiﬁcation trees with the highest
speciﬁcity in a conservative way. This means that the consensus model
only predicts a chemical as non-sensitiser if CT-1 and CT-2 have concor-
dant negative predictions.With any other combination of CT-1 and CT-2
the consensus model predicts a chemical to be a sensitiser. This combi-
nation is less accurate than a “pure consensus” model (i.e. concordantTable 8
Summary of results of deﬁned approaches andmodels published in 2015 for skin sensitisation h
positives (FP), false negatives (FN), sensitivity (Sens), speciﬁcity (Spec), accuracy (Acc), and tot
lications, and the values in parenthesis correspond to other models present in the same public
Measure This work (pure
consensus)a
Hirota et al. 2015 h-CLAT
& DPRA
(h-CLAT/SH test/ARE
assay)b
Takenouchi et al. (2015)
ITS (STS)c
TN 84 (84) 21 (10) 26 (20)
TP 166 (144) 92 (52) 91 (92)
FP 15 (1) 16 (11) 11 (17)
FN 4 (4) 10 (0) 11 (10)
Sens 0.98 (0.97) 0.90 (1.0) 0.89 (0.91)
Spec 0.85 (0.99) 0.57 (0.48) 0.70 (0.54)
Acc 0.93 (0.98) 0.81 (0.85) 0.84 (0.81)
n 269 (233) 139 (73) 139 (139)
a Data in brackets correspond to the values obtained if discordant results between CT-1 and
b Data corresponds to the artiﬁcial neural network model (ANN) for potency prediction tran
presented, ANN with h-CLAT and DPRA data, and ANN with h-CLAT, SH test, and ARE assay da
c Data corresponds to the integrated testing strategy (ITS) and to the sequential testing stra
d Data corresponds to the model that uses LuSens/MUSST values when no h-CLAT data is av
e Data corresponds to the performance of the training set and the test set. The latter set take
f Data corresponds to the performance of the model that combines global and local domain
g Data of set A corresponds to chemicals used in the training and test set. Set A is a balanced d
external validation set. Themodel is a pure consensusmodel andwhen the two sources are not
2015). This fact is reﬂected in the number of chemicals, which indicates the amount of chemicpositive and concordant negative predictions of CT-1 and CT-2), but al-
lows us to predict a larger amount of chemicals.
Since neither CT-1 nor CT-2 contain experimental descriptors, our
consensus model is not subject to physicochemical limitations like
water solubility or evaporation of the test chemical as it is the case for
in vitro/in chemicomethods and testing strategies based on their combi-
nation. The consensus model allows the prediction of a number of
chemicals within a few minutes, it has no inter- or intra-lab variability,
and only needs the chemical structure of the test chemical to obtain a
prediction. The main limitations of the consensus model are the fact
that it uses predictions from licensed software packages, that it can
only be used to predict organic chemicals with deﬁned structures (no
mixtures), and that some of the descriptors correspond to 3D descrip-
tors whose values depend on the 3D structure of the molecule, which
means that some predictions can be affected by the quality of the geo-
metrical optimisation process.
The higher accuracy of the consensus model (accuracy 0.93; n =
269) with respect to that of the validated and regulatory adopted indi-
vidual methods (accuracies of DPRA (0.77; n = 167), KeratinoSens™
(0.71; n = 223), and h-CLAT (0.77; n = 168)) is in line with the results
provided by other deﬁned approaches that use multiple readouts from
in silico and/or in chemico and/or in vitromethods (see Table 8).
In order to properly compare the performance of different ap-
proaches, the same set of chemicals should ideally be used since thepre-
dictive performance values are dependent on the set of chemicals
considered. In general, larger datasets will tend to have lower perfor-
mance statistics as the chemical structural diversity, reaction mecha-
nism and applicability domain will be larger and, therefore, the
models will be more general. It is beyond the scope of this analysis to
do a comprehensive comparison of available approaches for skin sensi-
tisation, which among other issues should take into account the differ-
ence in datasets used to develop and test each of the models.
Nevertheless, we made an attempt to benchmark the performance of
our model. Table 8 shows the performance statistics for some of the de-
ﬁned approaches for skin sensitisation that have been recently
published.
Our model shows an accuracy of 0.93 and has been tested with 269
chemicals. Other approaches available at the moment, i.e. Hirota et al.
(2015), Natsch et al. (2015), Urbisch et al. (2015), Alves et al. (2015),
or Takenouchi et al. (2015), show accuracies ranging from 0.81 to 0.84
except that of Jaworska et al. (2015) which shows an accuracy of 0.96.azard prediction against LLNA. The number of true negatives (TN), true positives (TP), false
al number of chemicals (n) are reported. The values were obtained from the original pub-
ation or to different sets of chemicals used in the publication.
Urbisch et al.
(2015)d
Jaworska et al.,
(2015)
Train. Set
(Test Set w/AD)e
Natsch et al.
(2015)f
Alves et al. (2015) Set A
(Set A & B)g
43 36 (14) 84 73 (74)
117 105 (46) 118 73 (123)
15 3 (0) 15 13 (13)
27 3 (0) 27 19 (43)
0.81 0.97 (1.0) 0.81 0.79 (0.74)
0.74 0.92 (1.0) 0.85 0.85 (0.85)
0.79 0.96 (1.0) 0.83 0.82(0.78)
202 147 (60) 244 178/254 (253/405)
CT-2 are considered as ambiguous.
slated into hazard by joining Cat 1A and Cat 1B into sensitisers. Data for two models are
ta.
tegy (STS) in parenthesis.
ailable.
s into account the applicability domain of the individual data inputs.
s.
ataset, and set B corresponds to chemicals that aremostly sensitisers and that were used as
concordant, the prediction is considered ambiguous and noprediction is given (Alves et al.,
als that were predicted from the total of chemicals present in each dataset.
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chemicals. Only the models proposed by Alves et al. have been tested
with more than 400 chemicals. However, many of their predictions
were considered inconclusive, and thus the approach was in reality
tested on 253 chemicals. The coverage of our consensus model would
be reduced to 233 chemicals (87%) if a pure consensus was applied.
The accuracy, sensitivity, and speciﬁcity would, however, be increased
to N0.97. Transforming our conservative consensusmodel to a pure con-
sensusmodel would affect one of its strong features, which is that it can
be applied to a large number of chemicals. In addition, we showed in
Table 7 that the fact that CT-1 and CT-2 are discordant is not necessarily
an indication of low conﬁdence in the prediction. In any case, when con-
sidering the performance of our consensus model and of the other de-
ﬁned approaches, one should bear in mind that these may be biased
by the datasets used and the uncertainty associated to the reference
data (Dumont et al., 2016).
Even though our model was optimised to predict LLNA classiﬁca-
tions, its performance in predicting human responses (Basketter et al.,
2014) appears satisfactory with an accuracy of 0.81, sensitivity of 0.90,
and speciﬁcity of 0.64. These predictive performance values are very
similar to those of the LLNA in predicting human data, which in our
dataset correspond to an accuracy of 0.80, sensitivity of 0.92, and spec-
iﬁcity of 0.58. These values show that ourmodel is capable of predicting
human skin sensitisation as accurately as the LLNA does.
The consensus model complies with the 5 OECD principles for the
validation of QSARs(OECD, 2004):
1) It predicts a well-deﬁned endpoint that is skin sensitisation hazard
(LLNA)
2) It has an unambiguous algorithm as it uses a conservative consensus
of classiﬁcation trees
3) It has a deﬁned applicability domain that consists of any organic
chemical with a deﬁned structure whose descriptors fall within the
limits shown in Fig. SI2 and SI3 of the Supporting Information
4) It has proper measures of goodness of ﬁt (see Table 3 and Table 8)
5) It has a mechanistic interpretation as it is based on the prediction of
protein binding considered to be the MIE of the skin sensitisation
AOP. This prediction is performed by TIMES-SS and the result is
modiﬁed or conﬁrmed by a series of descriptors thatmainly account
for chemical reactivity features as shown in Table 2
Thanks to the use of classiﬁcation treeswewere able to give qualita-
tive conﬁdencemeasures to each prediction depending on the combina-
tion of descriptors used to generate the prediction (see Table 6 and
Table 7). This measure of conﬁdence, although not being a quantitative
measure like the one provided by Bayesian models (Jaworska et al.,
2013, 2015) or decision forests (Tong et al., 2003), still gives an added
value to our model by providing a measure of uncertainty. In fact, pre-
dictions of very low or low conﬁdence are an indication that additional
evidence needs to be generated to come to a sound conclusion on the
lack or presence of skin sensitisation potential.
5. Conclusions
We have built a high quality dataset of 269 chemicals with in vivo
(Basketter et al., 2014), in chemico (Gerberick et al., 2007), and in vitro
(Ashikaga et al., 2006; Natsch and Emter, 2008) skin sensitisation
data. Thedataset has been obtained from the literature, test submissions
to EURL-ECVAM, and validation studies. The dataset has been complet-
ed with in silico predictions from several licensed and free software
packages (e.g. TIMES, Dragon, Vega, Derek Nexus, Dragon, or Toxtree)
and has been used to develop a predictive model for skin sensitisation
hazard (sensitiser/non-sensitiser). The collected human, LLNA, in
chemico, in vitro, and the in silico descriptors used in the model can be
found in the Supporting Information (SI_Dataset.xls).
The modelling exercise showed that skin sensitisation hazard, as
measured in the LLNA, was better predicted by classiﬁcation treesbased on in silico descriptors accounting for reactivity and structural fea-
tures, being TIMES-ProtBind the most discriminating one. TIMES-
ProtBind predicts the amount of test chemical that would bind to pro-
teins and accounts for skin metabolism and autoxidation processes. It
addresses the MIE of the skin sensitisation AOP (OECD, 2012a) and is
shown to correctly predict about 80% of the chemicals that are
mispredicted by the validated methods, DPRA, KeratinoSens™, and h-
CLAT.
A conservative consensus model of two classiﬁcation trees purely
based on in silico descriptors that predicts skin sensitisation hazard
(using LLNA classiﬁcations as a reference)with an accuracy of 0.93, sen-
sitivity of 0.98, and speciﬁcity of 0.85 for 269 chemicals is provided and
analysed in thismanuscript. The consensusmodel can be used topredict
organic substances with deﬁned chemical structures (mixtures, inor-
ganic substances and natural products cannot be predicted), and pro-
vides a qualitative measure of conﬁdence associated to the hazard
prediction. The model is very simple, can be implemented easily in dif-
ferent platforms, and complies with the OECD principles for the valida-
tion of QSARs (OECD, 2004).
In summary, we propose a deﬁned approach for predicting skin sen-
sitisation hazard that is highly accurate and sensitive, 100% reproduc-
ible, and fast. Depending on the user's acceptance criteria, the
predictions generated by our model may be adequate for the intended
purpose (e.g. hazard classiﬁcation), or may need to be combined with
other informationwithin aWoE approach that yields higher conﬁdence.
In applying a WoE approach, it is important to consider that our model
is optimised for the reliable identiﬁcation of negatives, so the “addition-
al weight” should focus on checking the positive predictions (to correct
for false positives). In this respect, little added value in predictive perfor-
mance is likely to be gained by applying an in chemico peptide binding
model, since this key (molecular initiating) event is well captured by
the TIMES- ProtBind descriptors in our model. A better information
gain is expected by follow up testing with one of the methods capable
of identifying downstream key events (i.e. keratinocyte activation, den-
dritic cell activation).
Ourmodel could also be used in a two-tiered strategy to predict skin
sensitisation potency where the ﬁrst step would be the identiﬁcation of
skin sensitisation potential. In case of a positive (sensitiser) prediction
in the ﬁrst step, the second step would determine whether the
sensitising effect is likely to be strong/extreme.
The next steps of our work will focus on the dissemination of the
model to make it publicly accessible and on the testing of additional
sets of chemicals to further challenge the model.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.tiv.2016.07.014.
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